ARTICLE | Clinical News
Symlin pramlintide: NDA under review
April 7, 2003 7:00 AM UTC
Interim16-week data from a 7-month dose-titration study of Symlin in 296 patients showed the use of a dose-titration protocol reduced nausea and the incidence of severe hypoglycemia during initiation ...